U.S. Markets
FDA says Moderna (MRNA) exposed participants, age 65 and over, to increased risk of severe illness by giving them a sub standard of care against the recommendation of FDA career scientists
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
